News

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...